Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Discord Invite Link Hijacking Delivers AsyncRAT and Skuld Stealer Targeting Crypto Wallets

A new malware campaign is exploiting a weakness in Discord’s invitation system to deliver an information stealer called Skuld and the AsyncRAT remote access trojan.

“Attackers hijacked the links through vanity link registration, allowing them to silently redirect users from trusted sources to malicious servers,” Check Point said in a technical report. “The attackers combined the ClickFix phishing technique, multi-stage loaders, and time-based evasions to stealthily deliver AsyncRAT, and a customized Skuld Stealer targeting crypto wallets.”

The issue with Discord’s invite mechanism is that it allows attackers to hijack expired or deleted invite links and secretly redirect unsuspecting users to malicious servers under their control. This also means that a Discord invite link that was once trusted and shared on forums or social media platforms could unwittingly lead users to malicious sites.

Common sleep aid blocks brain inflammation and tau buildup in Alzheimer’s model

Scientists have found that lemborexant not only increased restorative sleep in male mice but also reduced levels of toxic tau and brain inflammation. The findings suggest that targeting the brain’s orexin system may help slow Alzheimer’s progression.

Preventing stalling to improve CAR-T cells’ efficacy against tumors

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient’s own T cells, which are reprogrammed to fight their cancer. One of the limitations of CAR-T cell therapy is the ability of these cells to survive long enough to target the entire tumor.

Once injected back into the patient, the CAR-T cells tend to rapidly expand when they become activated by the , but eventually die off due to a natural process called activation-induced cell death.

In a study published in Science Translational Medicine, a research team discovered a way to alter CAR-T cells so they can partially avoid activation-induced cell death, which allows them to live longer and better fight off the tumor.